Economic impact of immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer: a single center observational study
This is the first report of the health economic benefits derived from preventing infections through Immunoglobulin Replacement Therapy (IgRT) in patients with secondary immunodeficiency due to hematological malignancies. We conducted a retrospective po…